Literature DB >> 20176005

Purification and characterization of functional human paraoxonase-1 expressed in Trichoplusia ni larvae.

Tamara C Otto1, Shane A Kasten, Elena Kovaleva, Zhi Liu, George Buchman, Marita Tolosa, David Davis, J Richard Smith, Robert Balcerzak, David E Lenz, Douglas M Cerasoli.   

Abstract

Human serum paraoxonase-1 (HuPON1) is difficult to either purify from plasma or functionally express in high yield from recombinant sources. Here, we describe the characterization of functional HuPON1 expressed and purified from Trichoplusia ni (T. ni) larvae infected with an orally active form of baculovirus. SDS-PAGE and anti-HuPON1 Western blot analyses yielded only three bands of approximately 41, 42, and 44 kDa. MALDI-TOF confirmed the identity of each of these bands as HuPON1 with greater than 95% confidence. These isoforms result from differential glycosylation of the enzyme as indicated by peptide mapping, mass analysis, and PNGase F deglycosylation experiments. Recombinant insect-produced HuPON1 hydrolyzed phenyl acetate, paraoxon, and the nerve agents GF, VX, and VR. The enzyme had dramatic stereoselectivity for the P+ isomers of VX and VR. T. ni larvae expressing HuPON1 were remarkably resistant to the pesticide chlorpyrifos. Together, these results demonstrate that the caterpillar of the T. ni moth can be used as an expression system to produce large quantities of functional recombinant HuPON1. Insect production of HuPON1 may provide a source for both in vitro enzymatic and crystallographic studies and in vivo stability and anti-nerve agent efficacy testing. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20176005     DOI: 10.1016/j.cbi.2010.02.022

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  8 in total

1.  Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme.

Authors:  Priyanka Bajaj; Rajan K Tripathy; Geetika Aggarwal; Abhay H Pande
Journal:  Protein Sci       Date:  2013-10-26       Impact factor: 6.725

2.  Structure of recombinant human carboxylesterase 1 isolated from whole cabbage looper larvae.

Authors:  Harry M Greenblatt; Tamara C Otto; Melanie G Kirkpatrick; Elena Kovaleva; Susan Brown; George Buchman; Douglas M Cerasoli; Joel L Sussman
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-02-15

Review 3.  Organophosphate-Hydrolyzing Enzymes as First-Line of Defence Against Nerve Agent-Poisoning: Perspectives and the Road Ahead.

Authors:  A R Satvik Iyengar; Abhay H Pande
Journal:  Protein J       Date:  2016-12       Impact factor: 2.371

4.  Trehalose Degradation by Cellvibrio japonicus Exhibits No Functional Redundancy and Is Solely Dependent on the Tre37A Enzyme.

Authors:  Cecelia A Garcia; Jackson A Narrett; Jeffrey G Gardner
Journal:  Appl Environ Microbiol       Date:  2020-10-28       Impact factor: 4.792

Review 5.  Current and emerging strategies for organophosphate decontamination: special focus on hyperstable enzymes.

Authors:  Pauline Jacquet; David Daudé; Janek Bzdrenga; Patrick Masson; Mikael Elias; Eric Chabrière
Journal:  Environ Sci Pollut Res Int       Date:  2016-02-02       Impact factor: 4.223

6.  VX hydrolysis by human serum paraoxonase 1: a comparison of experimental and computational results.

Authors:  Matthew W Peterson; Steven Z Fairchild; Tamara C Otto; Mojdeh Mohtashemi; Douglas M Cerasoli; Wenling E Chang
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

Review 7.  Human paraoxonase 1 as a pharmacologic agent: limitations and perspectives.

Authors:  Priyanka Bajaj; Rajan K Tripathy; Geetika Aggarwal; Abhay H Pande
Journal:  ScientificWorldJournal       Date:  2014-10-20

8.  Development of organophosphate hydrolase activity in a bacterial homolog of human cholinesterase.

Authors:  Patricia M Legler; Susanne M Boisvert; Jaimee R Compton; Charles B Millard
Journal:  Front Chem       Date:  2014-07-16       Impact factor: 5.221

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.